Enliven Therapeutics ELVN Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Enliven Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Enliven Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Enliven Therapeutics's earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Enliven Therapeutics's earnings yield?
- Enliven Therapeutics (ELVN) reported earnings yield of -4.2% in Q1 2026.
- How has Enliven Therapeutics's earnings yield changed year-over-year?
- Enliven Therapeutics's earnings yield increased by 57.1% year-over-year, from -9.8% to -4.2%.
- What is the long-term trend for Enliven Therapeutics's earnings yield?
- Over 5 years (2020 to 2025), Enliven Therapeutics's earnings yield has grown at a 1.2% compound annual growth rate (CAGR), from -10.7% to -11.3%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.